US HB4663 | 2019-2020 | 116th Congress

US Congress House Bill 4663 (Prior Session Legislation)

Status

Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on October 11 2019 - 25% progression, died in committee
Action: 2019-10-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.

Title

Freedom from Price Gouging Act

History

Date	Chamber	Action
2019-10-14	House	Referred to the Subcommittee on Health.
2019-10-11	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-10-11	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-10-11	House	Referred to the Subcommittee on Health.
2019-10-11	House	Introduced in House

Same As/Similar To

HB3 (Related) 2020-09-08 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.
HR758 (Similar To) 2019-12-11 - Mr. Nadler moved to table the motion to reconsider